Lincoln Pharmaceuticals Yönetim
Yönetim kriter kontrolleri 3/4
Lincoln Pharmaceuticals' CEO is Mahendrabhai Patel, appointed in Jun 2018, has a tenure of 6.42 years. total yearly compensation is ₹4.93M, comprised of 99.4% salary and 0.6% bonuses, including company stock and options. directly owns 6.52% of the company’s shares, worth ₹880.77M. The average tenure of the management team and the board of directors is 6 years and 10 years respectively.
Anahtar bilgiler
Mahendrabhai Patel
İcra Kurulu Başkanı
₹4.9m
Toplam tazminat
CEO maaş yüzdesi | 99.4% |
CEO görev süresi | 6.4yrs |
CEO sahipliği | 6.5% |
Yönetim ortalama görev süresi | 6yrs |
Yönetim Kurulu ortalama görev süresi | 10yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | ₹980m |
Mar 31 2024 | ₹5m | ₹5m | ₹933m |
Dec 31 2023 | n/a | n/a | ₹873m |
Sep 30 2023 | n/a | n/a | ₹808m |
Jun 30 2023 | n/a | n/a | ₹769m |
Mar 31 2023 | ₹3m | ₹3m | ₹729m |
Dec 31 2022 | n/a | n/a | ₹714m |
Sep 30 2022 | n/a | n/a | ₹674m |
Jun 30 2022 | n/a | n/a | ₹667m |
Mar 31 2022 | ₹3m | ₹3m | ₹694m |
Dec 31 2021 | n/a | n/a | ₹709m |
Sep 30 2021 | n/a | n/a | ₹668m |
Jun 30 2021 | n/a | n/a | ₹647m |
Mar 31 2021 | ₹3m | ₹3m | ₹623m |
Dec 31 2020 | n/a | n/a | ₹586m |
Sep 30 2020 | n/a | n/a | ₹560m |
Jun 30 2020 | n/a | n/a | ₹540m |
Mar 31 2020 | ₹2m | ₹2m | ₹514m |
Dec 31 2019 | n/a | n/a | ₹510m |
Sep 30 2019 | n/a | n/a | ₹492m |
Jun 30 2019 | n/a | n/a | ₹453m |
Mar 31 2019 | ₹2m | ₹2m | ₹487m |
Dec 31 2018 | n/a | n/a | ₹470m |
Sep 30 2018 | n/a | n/a | ₹495m |
Jun 30 2018 | n/a | n/a | ₹458m |
Mar 31 2018 | ₹2m | ₹2m | ₹346m |
Tazminat ve Piyasa: Mahendrabhai's total compensation ($USD58.57K) is below average for companies of similar size in the Indian market ($USD179.47K).
Tazminat ve Kazançlar: Mahendrabhai's compensation has increased by more than 20% in the past year.
CEO
Mahendrabhai Patel (70 yo)
6.4yrs
Görev süresi
₹4,925,000
Tazminat
Mr. Mahendrabhai Gulabdas Patel, B.A, LLB serves as Managing Director of Lincoln Pharmaceuticals Ltd since June 08, 2018. Mr. Patel has varied experience of chemicals, steel, finance etc. Mr. Patel handles...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
MD & Whole Time Director | 6.4yrs | ₹4.93m | 6.52% ₹ 880.8m | |
Chief Financial Officer | 5.7yrs | ₹1.32m | Veri yok | |
Company Secretary & Compliance Officer | 2yrs | ₹589.00k | Veri yok | |
Whole Time Director | no data | ₹6.64m | 10.6% ₹ 1.4b | |
Whole Time Director | 29.8yrs | ₹3.81m | 1.87% ₹ 251.9m | |
Whole Time Director | no data | ₹6.65m | 13.37% ₹ 1.8b | |
Senior Manager of Operation | no data | Veri yok | Veri yok | |
Vice President of Technical | no data | Veri yok | Veri yok | |
Senior Manager of Planning & Administration | no data | Veri yok | Veri yok | |
Group Marketing Manager | no data | Veri yok | Veri yok | |
Sales and Distributor Head | no data | Veri yok | Veri yok | |
Head of H R D | no data | Veri yok | Veri yok |
6.0yrs
Ortalama Görev Süresi
45.5yo
Ortalama Yaş
Deneyimli Yönetim: 531633's management team is seasoned and experienced (6 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
MD & Whole Time Director | 29.8yrs | ₹4.93m | 6.52% ₹ 880.8m | |
Whole Time Director | 10yrs | ₹6.64m | 10.6% ₹ 1.4b | |
Whole Time Director | 29.8yrs | ₹3.81m | 1.87% ₹ 251.9m | |
Whole Time Director | 10yrs | ₹6.65m | 13.37% ₹ 1.8b | |
Non-Executive Director | 29.8yrs | Veri yok | 3.78% ₹ 510.3m | |
Non-Executive Chairman | 29.3yrs | Veri yok | 2.39% ₹ 322.6m | |
Independent Non-Executive Director | 6.7yrs | Veri yok | Veri yok | |
Independent Director | less than a year | Veri yok | Veri yok | |
Woman Independent Director | less than a year | Veri yok | Veri yok |
10.0yrs
Ortalama Görev Süresi
64yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 531633's board of directors are seasoned and experienced ( 10 years average tenure).